Literature DB >> 32940

An increased Bohr effect in sickle cell anemia.

Y Ueda, R L Nagel, R M Bookchin.   

Abstract

Recent findings that hemoglobin S gelation and sickling are pH-dependent and also influence oxygen affinity suggested that the red cells containing this hemoglobin variant might show an abnormal Bohr effect. We therefore studied the effects of pH variation on the in vitro oxygen affinity of whole blood from persons with sickle cell anemia (SS) and normal donors (at 37 degrees C and constant carbon dioxide tension of 40 mm Hg). The Bohr effect in SS blood was greatly increased only between blood pH 7.4 and 7.2 (cell pH 7.2 and 7.0, a shift that strongly affects gelation), with delta log p50/deltapH= - 0.92 to -0.99 (normal = -0.42 to -0.46). Thus a drop in SS blood pH below 7.4 in tissue capillaries yields twice the normal decrease in oxygen affinity and a large release of oxygen from red cells, whose risk of sickling is high. Even mild transient acidosis would seem hazardous for patients with sickling disorders.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 32940

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  12 in total

Review 1.  Neuronal transient receptor potential (TRP) channels and noxious sensory detection in sickle cell disease.

Authors:  Katelyn E Sadler; Cheryl L Stucky
Journal:  Neurosci Lett       Date:  2018-11-30       Impact factor: 3.046

2.  Clinical correlates of steady-state oxyhaemoglobin desaturation in children who have sickle cell disease.

Authors:  Charles T Quinn; Naveed Ahmad
Journal:  Br J Haematol       Date:  2005-10       Impact factor: 6.998

3.  Automated oxyhemoglobin dissociation curve construction to assess sickle cell anemia therapy.

Authors:  R C Young; R E Rachal; M Del Pilar Aguinaga; B L Nelson; B C Kim; W P Winter; O Castro
Journal:  J Natl Med Assoc       Date:  2000-09       Impact factor: 1.798

4.  Cerebral tissue hemoglobin saturation in children with sickle cell disease.

Authors:  Charles T Quinn; Michael M Dowling
Journal:  Pediatr Blood Cancer       Date:  2012-06-07       Impact factor: 3.167

5.  Prospective evaluation of haemoglobin oxygen saturation at rest and after exercise in paediatric sickle cell disease patients.

Authors:  Andrew Campbell; Caterina P Minniti; Mehdi Nouraie; Manuel Arteta; Sohail Rana; Onyinye Onyekwere; Craig Sable; Gregory Ensing; Niti Dham; Lori Luchtman-Jones; Gregory J Kato; Mark T Gladwin; Oswaldo L Castro; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2009-08-19       Impact factor: 6.998

6.  Kinetics of increased deformability of deoxygenated sickle cells upon oxygenation.

Authors:  Zhi Huang; Leigh Hearne; Cynthia E Irby; S Bruce King; Samir K Ballas; Daniel B Kim-Shapiro
Journal:  Biophys J       Date:  2003-10       Impact factor: 4.033

7.  Haemoglobin oxygen saturation is a determinant of cerebral artery blood flow velocity in children with sickle cell anaemia.

Authors:  Charles T Quinn; Jennifer Variste; Michael M Dowling
Journal:  Br J Haematol       Date:  2009-03-05       Impact factor: 6.998

8.  Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.

Authors:  Paul Drawz; Sabarish Ayyappan; Mehdi Nouraie; Santosh Saraf; Victor Gordeuk; Thomas Hostetter; Mark T Gladwin; Jane Little
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-15       Impact factor: 8.237

9.  The relationship between maternal anemia and umbilical cord oxygen content at delivery.

Authors:  Virginia Y Watkins; Antonina I Frolova; Molly J Stout; Ebony B Carter; George A Macones; Alison G Cahill; Nandini Raghuraman
Journal:  Am J Obstet Gynecol MFM       Date:  2020-10-22

10.  Fetal Hemoglobin is Associated with Peripheral Oxygen Saturation in Sickle Cell Disease in Tanzania.

Authors:  Siana Nkya; Josephine Mgaya; Florence Urio; Abel Makubi; Swee Lay Thein; Stephan Menzel; Sharon E Cox; Charles R Newton; Fenella J Kirkham; Bruno P Mmbando; Julie Makani
Journal:  EBioMedicine       Date:  2017-08-08       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.